Skip to main content

Peer Review reports

From: Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience

Original Submission
18 Sep 2017 Submitted Original manuscript
22 Sep 2017 Author responded Author comments - Roland Schelker
Resubmission - Version 2
22 Sep 2017 Submitted Manuscript version 2
12 Oct 2017 Author responded Author comments - Roland Schelker
Resubmission - Version 3
12 Oct 2017 Submitted Manuscript version 3
2 Nov 2017 Author responded Author comments - Roland Schelker
Resubmission - Version 4
2 Nov 2017 Submitted Manuscript version 4
22 Nov 2017 Reviewed Reviewer Report - Craig Portell
24 Dec 2017 Reviewed Reviewer Report - Alejandro Gru
2 Jan 2018 Author responded Author comments - Roland Schelker
Resubmission - Version 5
2 Jan 2018 Submitted Manuscript version 5
24 Jul 2018 Reviewed Reviewer Report - Maurizio Martelli
29 Sep 2018 Author responded Author comments - Roland Schelker
Resubmission - Version 6
29 Sep 2018 Submitted Manuscript version 6
Publishing
1 Oct 2018 Editorially accepted
19 Oct 2018 Article published 10.1186/s12885-018-4885-5

You can find further information about peer review here.

Back to article page